Cargando…

Autologous Stem Cell Transplantation in Multiple Myeloma: Where Are We and Where Do We Want to Go?

The introduction of high-dose therapy in the 1990s as well as the development of drugs such as thalidomide, lenalidomide, and bortezomib in the 2000s led to an impressive improvement in outcome of patients with multiple myeloma (MM) eligible for autologous stem cell transplantation (ASCT). Clinical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morè, Sonia, Corvatta, Laura, Manieri, Valentina Maria, Saraceni, Francesco, Scortechini, Ilaria, Mancini, Giorgia, Fiorentini, Alessandro, Olivieri, Attilio, Offidani, Massimo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870632/ https://www.ncbi.nlm.nih.gov/pubmed/35203257 http://dx.doi.org/10.3390/cells11040606

Ejemplares similares

Joint Discussion – Where we stand and where we want to go
por: CERN. Geneva
Publicado: (2013)

Joint Discussion – Where we stand and where we want to go
por: CERN. Geneva
Publicado: (2013)

Intensive Care Medicine: Where We Are and Where We Want To Go?
por: Moreno, R. P., et al.
Publicado: (2011)

Current Main Topics in Multiple Myeloma
por: Morè, Sonia, et al.
Publicado: (2023)

Moving Beyond Heading. How Does the Brain Reconcile where we are Going with where we Want to Go?
por: Wann, John
Publicado: (2011)

P973: ATTRITION PROBABILITY AND PREDICTORS AMONG MULTIPLE MYELOMA PATIENTS TREATED IN AN ITALIAN HAEMATOLOGICAL TERTIARY CARE CENTRE
por: More’, Sonia, et al.
Publicado: (2023)

P912: ADDING REFRACTORINESS STATUS TO LINES OF THERAPY BETTER DEFINE PROGNOSIS OF A REAL LIFE ITALIAN MULTIPLE MYELOMA POPULATION
por: More’, Sonia, et al.
Publicado: (2023)

Novel Experimental Drugs for Treatment of Multiple Myeloma
por: Offidani, Massimo, et al.
Publicado: (2021)

The Clusmy Child: Where Are We and Where Are We Going?
por: Hadders-Algra, Mijna, et al.
Publicado: (2003)

European HEPnet: where we are and where we are going
por: Carpenter, B E, et al.
Publicado: (1990)

Iron health: where are we and where are we going?
por: Gotardo, Glória Ines Beal
Publicado: (2011)

Hip Arthroscopy: Where We Are, and Where We Are Going
por: Park, Myung Sik, et al.
Publicado: (2015)

Bioactive Glasses: Where Are We and Where Are We Going?
por: Baino, Francesco, et al.
Publicado: (2018)

Diabetic cardiomyopathy: where we are and where we are going
por: Lee, Wang-Soo, et al.
Publicado: (2017)

Obstetric ultrasound: where are we and where are we going?
por: Abramowicz, Jacques S
Publicado: (2021)

Hidradenitis Suppurativa: Where We Are and Where We Are Going
por: Scala, Emanuele, et al.
Publicado: (2021)

Where We Are and Where We Are Going in Nut Research
por: Salas-Salvadó, Jordi, et al.
Publicado: (2023)

COVID-19: Where We Are and Where We Are Going
por: Abenavoli, Ludovico, et al.
Publicado: (2023)

Telemedicine in ophthalmology - where are we and where are we going?
por: Pîrvulescu, Ruxandra
Publicado: (2023)

Belantamab Mafodotin for the Treatment of Multiple Myeloma: An Overview of the Clinical Efficacy and Safety
por: Offidani, Massimo, et al.
Publicado: (2021)

Where are we coming from? What are we? Where are we going?
por: Ellis, John R.
Publicado: (1995)

The living universe: where are we? who are we? where are we going?
por: Elgin, Duane, et al.
Publicado: (2009)

The Challenge Arising from New Knowledge about Immune and Inflammatory Skin Diseases: Where We Are Today and Where We Are Going
por: Campanati, Anna, et al.
Publicado: (2022)

Where are we going?
por: Pawl, Ronald P.
Publicado: (2010)

P47 REAL-WORLD DATA OF ATTRITION RATES BY SUBSEQUENT LINES OF THERAPY IN MULTIPLE MYELOMA PATIENTS TREATED IN A TERTIARY CARE ITALIAN CENTRE
por: Morè, S., et al.
Publicado: (2023)

Vesicoureteral Reflux: Where Have We Been, Where Are We Now, and Where Are We Going?
por: McLorie, Gordon A.
Publicado: (2008)

TSACO’s Third Anniversary: where we were, where we are, and where we’re going
por: Fabian, Timothy
Publicado: (2019)

Anticipation in Lynch Syndrome: Where We Are Where We Go
por: Bozzao, Cristina, et al.
Publicado: (2011)

Free software at CERN: where are we, where are we going?
por: Fluckiger, Francois, et al.
Publicado: (2013)

Molecular targeted agents—where we are and where we are going
por: Yan, Li
Publicado: (2013)

Dermatology: Where are We Coming from and Where are We Going to?
por: van de Kerkhof, Peter C. M.
Publicado: (2014)

CUREs in biochemistry—where we are and where we should go
por: Bell, Jessica K., et al.
Publicado: (2016)

Colon Capsule Endoscopy: Where Are We and Where Are We Going
por: Han, Yoo Min, et al.
Publicado: (2016)

Chronic Pulmonary Aspergillosis—Where Are We? and Where Are We Going?
por: Hayes, Gemma E., et al.
Publicado: (2016)

Accommodative intraocular lenses: where are we and where we are going
por: Alió, Jorge L., et al.
Publicado: (2017)

Research in Vascular Medicine: Where We Are and Where We Are Going
por: Qanadli, Salah D.
Publicado: (2020)

Single-use duodenoscopes: where are we and where are we going?
por: Peter, Shajan, et al.
Publicado: (2021)

Pediatric Sepsis Research: Where Are We and Where Are We Going?
por: Massaud-Ribeiro, Letícia, et al.
Publicado: (2022)

Nuclear‐medicine probes: Where we are and where we are going
por: Gonzalez‐Montoro, Andrea, et al.
Publicado: (2022)

Mathematics anxiety—where are we and where shall we go?
por: Cipora, Krzysztof, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e8cd6cfnt0087p295snn13i20f